Fundamental analysis of $KEQU (KEWAUNEE SCIENTIFIC CORP /DE/) based on financial data and reported results.

#KEQU

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026 Kewaunee Scientific (NASDAQ: KEQU) reported fiscal 2026 third quarter results for the period ended January 31, 2026. Net sales were $69,399,000, up 3.3% year-over-year. Pre-tax earnings were $1,604,000 (+25.8%), while net earnings declined to $692,000 from $1,354,000. Diluted EPS was $0.23 versus $0.45 a year earlier.The Company's order backlog was $183.2 million, cash on hand $10.347 million, and debt-to-equity was 0.68-to-1. Management noted integration of the acquired Nu Aire and continued corporate investments supporting growth and SEC reporting readiness.

#KEQU Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026 Sales during the second quarter of fiscal year 2026 were $70,096,000, an increase of 46.8% compared to sales of $47,764,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,453,000 compared to $3,931,000 for the prior year quarter, a decrease of 12.2%. The Company's order backlog was $192. 9 million on October 31, 2025, as compared...

#KEQU Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc. Kewaunee Scientific (NASDAQ: KEQU) announced on Dec 4, 2025 that it fully repaid its Seller Notes tied to the Nu Aire acquisition. The Seller Notes had an original principal of $23.0 million and were scheduled to mature Nov 1, 2027. Repayment was funded via an amendment to the Nov 1, 2024 loan agreement with PNC, which provided a $10.0 million term loan and permitted use of available revolving credit.The company said the transactions lower overall debt, reduce the effective interest rate, and materially cut expected future interest expense while supporting strategic growth plans.

#KEQU Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026 Kewaunee Scientific (NASDAQ: KEQU) reported strong Q1 FY2026 results with sales reaching $71.1 million, up 46.9% year-over-year. The company achieved net earnings of $3.1 million ($1.04 per diluted share), compared to $2.2 million ($0.74 per share) in the prior year.The company's order backlog stood at $205.0 million as of July 31, 2025, up from $159.4 million year-over-year. Domestic segment sales increased 53.0% to $54.4 million, while International segment sales grew 30.2% to $16.8 million. The growth was partially driven by the incorporation of Nu Aire's results, following its acquisition in November 2024.Despite anticipating uneven quarterly performance for the remainder of FY2026, management expects to deliver improved unadjusted EBITDA compared to FY2025, while continuing strategic investments in corporate infrastructure. [ "Sales increased significantly by 46.9% to $71.1 million year-over-year", "Net earnings grew 41% to $3.1 million compared to prior year", "Strong order backlog of $205.0 million, up 28.6% from prior year", "Domestic segment sales surged 53.0% to $54.4 million", "International segment sales increased 30.2% to $16.8 million", "Debt-to-equity ratio improved to 0.94-to-1 from 0.99-to-1" ]

#KEQU Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Corporation (NASDAQ: KEQU) reported strong financial results for Q4 and fiscal year 2025. Q4 sales reached $77.1 million, up 36.1% year-over-year, with net earnings of $4.85 million and diluted EPS of $1.63. The company's order backlog stood at $214.6 million as of April 30, 2025.The company completed the acquisition of Nu Aire, Inc. on November 1, 2024, strengthening its laboratory equipment portfolio. For the full fiscal year 2025, sales increased 18% to $240.5 million, with net earnings of $11.4 million. Adjusted for acquisition costs, fiscal year 2025 adjusted diluted EPS was $5.37, compared to $4.19 in the prior year.The Domestic segment showed particularly strong performance with sales up 54.7% in Q4, while International segment sales increased by 3.9%. The company maintains a healthy financial position with $17.2 million in cash and a debt-to-equity ratio of 0.99-to-1.

#KEQU Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Enhances Share Repurchase Program for Stockholders' Value Kewaunee Scientific Corporation has announced an enhancement to its current share repurchase program to benefit its shareholders, reflecting their ongoing financial strategy.

Kewaunee Scientific Enhances Share Repurchase Program for Stockholders' Value #United_States #Nu_Aire #KEQU #Statesville #Kewaunee_Scientific

Kewaunee Scientific Boosts Share Repurchase Program Following Strategic Acquisition Kewaunee Scientific resumes and expands share repurchase program with 100,000 additional shares following Nu Aire acquisition, signaling management confidence in growth strategy.

#KEQU Kewaunee Scientific Announces Amendment to Share Repurchase Program

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025 Kewaunee Scientific (NASDAQ: KEQU) reported its Q3 FY2025 results with sales of $67.17 million, up 43.6% year-over-year. However, pre-tax earnings decreased 63.7% to $1.28 million, with diluted EPS falling to $0.45 from $0.85.The quarter included costs related to the Nu Aire acquisition, completed on November 1, 2024. Adjusting for acquisition and integration costs of $2.51 million, adjusted pre-tax earnings were $3.79 million, up 7.8% YoY, with adjusted EPS of $1.09.Key metrics include:Order backlog: $221.6 million (up from $152.3 million YoY)Domestic sales: $51.98 million (+63.6% YoY)International sales: $15.19 million (+1.2% YoY)Cash position: $12.34 millionDebt-to-equity ratio: 1.29-to-1The company's Domestic segment showed strong performance, while the International segment faced challenges due to customer site delays. Management remains focused on operational excellence and strategic growth initiatives.

#KEQU Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Hits Record $184M Backlog Despite Revenue Dip; Completes Strategic Nu Aire Acquisition Mixed Q2 results show 5.3% revenue decline but record $184.4M order backlog. Domestic sales up 6.5% while international faces headwinds. Strategic Nu Aire acquisition expands portfolio.

#KEQU Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

#investing #stocks #StockMarket

www.stocktitan.net/news/KEQU/kewaunee-scien...

Kewaunee Scientific Corporation Announces Upcoming Financial Results for Second Quarter Fiscal Year 2025 Kewaunee Scientific Corporation will share its fiscal year 2025 second quarter results on December 11, 2024, after trading closes.

Kewaunee Scientific Corporation Announces Upcoming Financial Results for Second Quarter Fiscal Year 2025 #USA #Kewaunee #Nu_Aire #KEQU #Statesville

Breaking News: ( NASDAQ: #KEQU ) Kewaunee Scientific Corp. (NASDAQ: KEQU) Highlighted for Surprising Price Action

#StockMarket #News

BREAKING NEWS: ( NASDAQ: #KEQU ) Kewaunee Scientific Corporation Completes Acquisition of Nu Aire

#StockMarket #News